true Q3 --12-31 0001388295 P10Y P5Y P5Y P5Y 0001388295 2024-01-01 2024-09-30 0001388295 2024-09-30 0001388295 2023-12-31 0001388295 us-gaap:NonrelatedPartyMember 2024-09-30 0001388295 us-gaap:NonrelatedPartyMember 2023-12-31 0001388295 us-gaap:RelatedPartyMember 2024-09-30 0001388295 us-gaap:RelatedPartyMember 2023-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001388295 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2023-12-31 0001388295 2024-07-01 2024-09-30 0001388295 2023-07-01 2023-09-30 0001388295 2023-01-01 2023-09-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-12-31 0001388295 us-gaap:CommonStockMember 2023-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001388295 us-gaap:RetainedEarningsMember 2023-12-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-03-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-03-31 0001388295 us-gaap:CommonStockMember 2024-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001388295 us-gaap:RetainedEarningsMember 2024-03-31 0001388295 2024-03-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-06-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-06-30 0001388295 us-gaap:CommonStockMember 2024-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001388295 us-gaap:RetainedEarningsMember 2024-06-30 0001388295 2024-06-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2022-12-31 0001388295 us-gaap:CommonStockMember 2022-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001388295 us-gaap:RetainedEarningsMember 2022-12-31 0001388295 2022-12-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-03-31 0001388295 us-gaap:CommonStockMember 2023-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001388295 us-gaap:RetainedEarningsMember 2023-03-31 0001388295 2023-03-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-06-30 0001388295 us-gaap:CommonStockMember 2023-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001388295 us-gaap:RetainedEarningsMember 2023-06-30 0001388295 2023-06-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001388295 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001388295 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001388295 2024-01-01 2024-03-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-04-01 2024-06-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001388295 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001388295 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001388295 2024-04-01 2024-06-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-07-01 2024-09-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-07-01 2024-09-30 0001388295 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001388295 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001388295 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001388295 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001388295 2023-01-01 2023-03-31 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-04-01 2023-06-30 0001388295 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001388295 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001388295 2023-04-01 2023-06-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-07-01 2023-09-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-07-01 2023-09-30 0001388295 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001388295 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-09-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-09-30 0001388295 us-gaap:CommonStockMember 2024-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001388295 us-gaap:RetainedEarningsMember 2024-09-30 0001388295 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-09-30 0001388295 us-gaap:PreferredStockMember ONEI:SeriesBOneConvertiblePreferredStockMember 2023-09-30 0001388295 us-gaap:CommonStockMember 2023-09-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001388295 us-gaap:RetainedEarningsMember 2023-09-30 0001388295 2023-09-30 0001388295 us-gaap:BuildingImprovementsMember 2024-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2024-07-01 2024-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2023-07-01 2023-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2024-01-01 2024-09-30 0001388295 ONEI:SubscriptionAndLicenseMember 2023-01-01 2023-09-30 0001388295 ONEI:TrainingAndEducationMember 2024-07-01 2024-09-30 0001388295 ONEI:TrainingAndEducationMember 2023-07-01 2023-09-30 0001388295 ONEI:TrainingAndEducationMember 2024-01-01 2024-09-30 0001388295 ONEI:TrainingAndEducationMember 2023-01-01 2023-09-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-09-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-09-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-06-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-01 2023-06-30 0001388295 2023-01-01 2023-06-30 0001388295 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-09-30 0001388295 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-01 2023-09-30 0001388295 ONEI:RowlandDayMember 2024-01-01 2024-09-30 0001388295 ONEI:RowlandDayMember 2024-09-30 0001388295 ONEI:RowlandDayMember 2023-01-01 2023-09-30 0001388295 ONEI:RowlandDayMember 2023-12-31 0001388295 ONEI:SaulLealMember 2024-01-01 2024-09-30 0001388295 ONEI:SaulLealMember 2024-09-30 0001388295 ONEI:RowlandDayMember us-gaap:ConvertibleDebtMember 2024-01-01 2024-09-30 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOneConvertiblePreferredStockMember 2024-09-30 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-05-10 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-05-10 2024-05-10 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-06-12 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-06-12 2024-06-12 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-08-12 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-08-12 2024-08-12 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-08-27 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-08-27 2024-08-27 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-09-26 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-09-26 2024-09-26 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2024-09-30 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember 2023-12-31 0001388295 ONEI:RowlandDayMember 2023-01-01 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2023-05-01 0001388295 2024-02-06 2024-02-06 0001388295 2024-02-06 0001388295 us-gaap:SeriesAPreferredStockMember 2008-04-30 0001388295 us-gaap:SeriesAPreferredStockMember 2023-05-01 0001388295 us-gaap:SeriesAPreferredStockMember 2023-05-01 2023-05-01 0001388295 ONEI:SeriesAOnePreferredStockMember 2024-09-30 0001388295 ONEI:SeriesAOnePreferredStockMember 2023-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember 2015-10-01 2015-10-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockMember ONEI:MetalanguageMember 2023-05-02 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2015-10-31 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2015-10-01 2015-10-31 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2024-09-30 0001388295 ONEI:SeriesBTwoConvertiblePreferredStockMember 2023-12-31 0001388295 us-gaap:WarrantMember 2024-09-30 0001388295 us-gaap:EmployeeStockOptionMember srt:DirectorMember 2024-01-24 2024-01-24 0001388295 us-gaap:EmployeeStockOptionMember srt:DirectorMember 2024-01-24 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-05 2024-08-05 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-05 0001388295 us-gaap:EmployeeStockOptionMember srt:DirectorMember us-gaap:EmployeeStockMember 2024-08-05 2024-08-05 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-19 2024-08-19 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember 2024-08-19 0001388295 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001388295 us-gaap:EmployeeStockOptionMember 2024-09-30 0001388295 us-gaap:WarrantMember 2023-12-31 0001388295 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001388295 us-gaap:EmployeeStockOptionMember 2023-12-31 0001388295 ONEI:OEMAgreementMember us-gaap:SubsequentEventMember 2024-10-08 2024-10-08 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember us-gaap:SubsequentEventMember 2024-10-14 0001388295 ONEI:RowlandDayMember ONEI:SeniorSecuredPromissoryNotesPayableMember us-gaap:SubsequentEventMember 2024-10-14 2024-10-14 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:EmployeeStockMember us-gaap:SubsequentEventMember 2024-10-29 2024-10-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment No.1)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________to ________.

 

Commission File Number 000-56565

 

ONEMETA INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-5150818

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

450 South 400 Esat, Suite 200, Bountiful, UT 84010

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (702) 550-0122

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of exchange on which registered
None.        

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐

Accelerated Filer

Non-Accelerated Filer Smaller Reporting Company Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date.

 

Title or class   Shares outstanding as of September 30, 2024
Common Stock, $0.001 par value   33,964,960
     
Series A Preferred, $0.001 par value   2,068
     
Series B-1 Convertible Preferred, $0.001 par value   8,619,420

 

 

 

 

 

 

Explanatory Note

 

This Amendment No. 1 to Form 10-Q (this “Amendment” or “Amendment No. 1”) amends the Quarterly Report on Form 10-Q for the period ended September 30, 2024 originally filed on November 13, 2024 (the “Original Filing”) by OneMeta, Inc., a Nevada corporation (“ONEI,” the” Company,” “we,” or “us”). We are filing this Amendment to restate our financial statements as of and for the periods ending June 30, 2023 and September 30, 2023 (collectively, the “Previous Financial Statements”). The Previous Financial Statements are restated to correct the valuation of additional shares issued for prior year software acquisition on May 2, 2023.

 

The impact of this error is limited to the Company’s results of operation, loss per share, and the error did not impact the Company’s revenue, or net equity. The error has not resulted in any change to the Company’s business plan or operations and does not impact any regulatory requirements or management compensation.

 

This Amendment does not reflect events occurring after the filing of our Original Filing, or modify or update those disclosures, except as disclosed in our financial statement footnote subsequent event disclosures. The following sections of our Original Filing have been amended:

 

● Part I – Item 1 - Financial Information of our Original Filing has been amended; and

● Part II - Item 4 - Controls and Procedures

 

This Amendment has been signed as of a current date and all certifications of our Chief Executive Officer and Chief Financial Officer are given as of a current date. Accordingly, this Amendment should be read in conjunction with our filings made with the Securities and Exchange Commission subsequent to the filing of the Original Filing.

 

 

 

 

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION 3
     
Item 1. Financial Statements (Unaudited) 3
     
  Balance Sheets 3
     
  Statements of Operations 4
     
  Statements of Changes in Stockholders’ Equity (Deficit) 5
     
  Statements of Cash Flows 6
     
  Notes to Financial Statements (Unaudited) 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
     
Item 4. Controls and Procedures 23
     
PART II. OTHER INFORMATION 24
     
Item 1. Legal Proceedings 24
     
Item 1A. Risk Factors 24
     
Item 6. Exhibits 25
     
SIGNATURES 26

 

2

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

ONEMETA INC.

BALANCE SHEETS

(Unaudited)

 

   September 30,
2024
   December 31,
2023
 
         
ASSETS          
Current assets:          
Cash  $24,254   $1,129,935 
Accounts receivable   6,160    6,935 
Prepaid and other current assets   16,192    6,820 
Total current assets   46,606    1,143,690 
           
Total assets  $46,606   $1,143,690 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable  $583,152   $522,917 
Accrued expenses   23,031    - 
Accrued expenses, related party   471,658    281,012 
Deferred revenue   16,000    - 
Note payable, related party   221,990    221,990 
Senior secured notes payable, related party   549,000    - 
Total current liabilities   1,864,831    1,025,919 
Total liabilities   1,864,831    1,025,919 
           
Commitments and contingencies   -    - 
           
STOCKHOLDERS’ EQUITY (DEFICIT)          
Preferred stock, $0.001 par value, 50,000,000 shares authorized,          
Series A preferred stock, $0.001 par value, 2,068 shares authorized, 2,068
 issued and outstanding
   2    2 
Series B-1 convertible preferred stock, $0.001 par value, 8,619,420 shares authorized, 8,619,420 shares issued and outstanding   862    862 
Common stock, $0.001 par value, 500,000,000 shares authorized,
33,964,960 and 32,995,460 shares issued and outstanding, respectively
   33,965    32,996 
Additional paid in capital   34,998,705    33,992,707 
Accumulated deficit   (36,851,759)   (33,908,796)
Total stockholders’ equity (deficit)   (1,818,225)   117,771 
Total liabilities and stockholders’ equity (deficit)  $46,606   $1,143,690 

 

See accompanying notes to the unaudited financial statements.

 

3

 

 

ONEMETA INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three months ended   Three months ended   Nine months ended   Nine months ended 
   September 30, 2024   September 30, 2023   September 30, 2024   September 30,
2023
 
               As Restated 
Revenue  $3,478   $9,162   $14,354   $57,124 
Total revenue   3,478    9,162    14,354    57,124 
                     
Operating expenses:                    
Research and development   202,168    203,588    653,732    540,092 
General and administrative   537,164    515,146    1,672,388    3,455,292 
Advertising and marketing   25,336    71,253    78,809    161,038 
Legal and professional   139,600    265,893    491,733    387,809 
                     
Total operating expenses   904,268    1,055,880    2,896,662    4,544,231 
                     
Loss from operations   (900,790)   (1,046,718)   (2,882,308)   (4,487,107)
                     
Other expense:                    
                     
Interest expense   (34,563)   (10,990)   (60,655)   (31,462)
                     
Total other expense   (34,563)   (10,990)   (60,655)   (31,462)
                     
Net loss  $(935,353)  $(1,057,708)  $(2,942,963)  $(4,518,569)
                     
Net loss per common share:                    
Basic  $(0.03)  $(0.03)  $(0.09)  $(0.16)
Diluted  $(0.03)  $(0.03)  $(0.09)  $(0.16)
                     
Weighted average common shares outstanding:                    
Basic   33,721,004    30,224,461    33,312,494    27,820,812 
Diluted   33,721,004    30,224,461    33,312,494    27,820,812 

 

See accompanying notes to the unaudited financial statements.

 

4

 

 

ONEMETA INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the nine months ended September 30, 2024 and 2023

(Unaudited)

 

   Shares   Amount     Shares   Amount   Shares   Amount   Shares   Amount   capital   Deficit   Total 
   Series B-1 Convertible Preferred Stock     Series A Preferred Stock   Series B-1 Convertible Preferred Stock   Common Stock  

Additional

paid-in

   Accumulated     
   Shares   Amount     Shares   Amount   Shares   Amount   Shares   Amount   capital   Deficit   Total 
                                               
Balance, December 31, 2023   -   $-      2,068   $2    8,619,420   $862    32,995,460   $32,996   $33,992,707   $(33,908,796)  $117,771 
Common shares issued for cash   -    -      -    -    -    -    87,500    87    34,913    -    35,000 
Stock based compensation   -    -      -    -    -    -    -    -    84,663    -    84,663 
Contributed capital   -    -      -    -    -    -    -    -    4,448    -    4,448 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (937,097)   (937,097)
Balance, March 31, 2024   -    -      2,068    2    8,619,420    862    33,082,960    33,083    34,118,396    (34,845,893)   (693,550)
Common shares issued for cash   -    -      -    -    -    -    582,000    582    465,018    -    465,600 
Stock based compensation   -    -      -    -    -    -    -    -    92,338    -    92,338 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (1,070,513)   (1,070,513)
Balance, June 30, 2024   -    -      2,068    2    8,619,420    862    33,664,960    33,665    34,677,417    (35,916,406)   (1,204,460)
Common shares issued for cash   -    -      -    -    -    -    300,000    300    224,700    -    225,000 
Stock based compensation   -    -      -    -    -    -    -    -    94,923    -    94,923 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (935,353)   (935,353)
Balance, September 30, 2024   -   $-      2,068   $2    8,619,420   $862    33,964,960   $33,965   $34,998,705   $(36,851,759)  $(1,818,225)
                                                          
Balance, December 31, 2022   5,673,346   $4,016,616      2,068   $2    -   $-    24,983,593   $24,984   $24,156,001   $(27,761,733)   (3,580,746)
Common shares issued for cash   -    -      -    -    -    -    437,500    437    174,563    -    175,000 
Stock based compensation   -    -      -    -    -    -    30,000    30    11,970    -    12,000 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (542,413)   (542,413)
Balance, March 31, 2023   5,673,346    4,016,616      2,068    2    -    -    25,451,093    25,451    24,344,199    (28,304,146)   (3,934,494)
Common shares issued for cash   -    -      -    -    -    -    2,936,667    2,937    1,005,063    -    1,008,000 
Additional shares issued for prior year
 software acquisition
   2,946,074    2,085,762      -    -    -    -    1,772,800    1,773    131,187    -    132,960 
Stock based compensation   -    -      -    -    -    -    -    -    79,666    -    79,666 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (2,918,448)   (2,918,448)
Balance, June 30, 2023 – As Restated   8,619,420    6,102,378      2,068    2    -    -    30,160,560    30,161    25,561,780    (31,222,594)   (5,630,651)
Common shares issued for cash   -    -      -    

-
    

-
        437,500    437    174,563    -    175,000 
Stock based compensation   -    -      -    -    -    -    50,000    50    54,146    -    54,196 
Reclassification of mezzanine equity   (8,619,420)   (6,102,378)     -    -    8,619,420    862    -    -    6,101,516    -    6,102,378 
Imputed interest   -    -      -    -    -    -    -    -    1,665    -    1,665 
Net loss   -    -      -    -    -    -    -    -    -    (1,057,708)   (1,057,708)
Balance, September 30, 2023 – As Restated   -   $-      2,068   $2    8,619,420   $862    30,648,060   $30,648   $31,893,670   $(32,280,302)  $(355,120)

 

See accompanying notes to the unaudited financial statements.

 

5

 

 

ONEMETA INC.

STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2024 and 2023

(Unaudited)

 

   September 30, 2024   September 30, 2023 
   As Restated 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(2,942,963)  $(4,518,569)
Adjustment to reconcile net loss to cash used in operating activities:          
Imputed interest   4,995    4,995 
Additional shares issued for prior year software acquisition   -    2,218,722 
Stock based compensation   271,924    145,862 
Amortization   -    293,857 
Net change in:          
Accounts receivable   775    (12,135)
Prepaid and other current assets   (9,372)   - 
Accounts payable   318,210    447,693 
Accrued expenses   23,031    - 
Accrued expenses, related party   (62,881)   (125,883)
Deferred revenue   16,000    - 
           
CASH FLOWS USED IN OPERATING ACTIVITIES   (2,380,281)   (1,545,458)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from senior secured notes payable, related party   549,000    - 
Proceeds from issuance of common shares   725,600    1,358,000 
Proceeds from advances, related party   72,000    - 
Repayment of advances, related party   (72,000)   - 
           
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES   1,274,600    1,358,000 
           
NET CHANGE IN CASH   (1,105,681)   (187,458)
Cash, beginning of period   1,129,935    400,703 
Cash, end of period  $24,254   $213,245 
           
SUPPLEMENTAL CASH FLOW INFORMATION          
           
Cash paid on interest expense  $-   $- 
Cash paid for income taxes  $-   $- 
           
NON-CASH TRANSACTIONS          
Expenses paid on the Company’s behalf  $257,975   $352,952 
Contributed capital  $4,448   $- 
Reclassification of mezzanine equity  $-   $6,102,378 

 

See accompanying notes to the unaudited financial statements.

 

6

 

 

OneMeta Inc.

(Formerly OneMeta AI)

Notes to the Financial Statements

(Unaudited)

 

Note 1. Basis of Presentation

 

The accompanying unaudited interim financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the financial statements and notes thereto contained in the Company’s fiscal 2023 financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the financial statements for fiscal 2023, have been omitted.

 

OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

 

Note 2. Summary of Significant Accounting Policies

 

Use of Estimates

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of common stock and stock based compensation.

 

Cash and Cash Equivalents

 

Cash equivalents include all highly liquid investments with original maturities of three months or less.

 

Accounts Receivable

 

Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances. As of September 30, 2024 and December 31, 2023, there was no allowance for credit losses.

 

Property and Equipment

 

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:

 

   Estimated
Category  Useful Lives
Building and improvements  3 years

 

7

 

 

Related Parties

 

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

Identification of the contract with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the performance obligations in the contract
Recognition of revenue when, or as, the Company satisfies a performance obligation

 

We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software.

 

We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service.

 

Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient.

 

Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed.

 

8

 

 

Disaggregation of revenues

 

The Company disaggregates revenue between subscription and license revenue and training and education revenue.

 

   Three Months Ended September 30, 2024   Three Months Ended September 30, 2023   Nine Months Ended September 30, 2024   Nine Months Ended September 30, 2023 
Subscription and license revenue  $-   $3,387   $10,876   $44,674 
Training and education   3,478    5,775    3,478    12,450 
Total revenue  $3,478   $9,162   $14,354   $57,124 

 

Deferred Revenue

 

Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. As of September 30, 2024 and 2023, deferred revenue was $16,000 and $0, respectively.

 

Basic and Diluted Loss Per Share

 

Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the nine months ended September 30, 2024 and 2023, reflected in the accompanying statement of operations.

 

Recent Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

 

Note 3. Restatement of Previously Issued Unaudited Interim Financial Statements

 

In the course of preparing its fiscal year 2024 financial statements and reviewing comments from the Securities and Exchange Commission in relation to its Annual Report on Form 10-K for the year ended December 31, 2023, the Company identified errors in the financial statements for the its unaudited financial statements for the periods ended June 30, 2024, and September 30, 2024(the “Interim Periods” or the “Affected Periods”). The errors pertain to overstatements in general and administrative expenses and additional paid in capital amounting to $576,160 the six months ended June 30, 2023 and the nine months ended September 30, 2023 resulting from the Company using the stock price from the most recent offering rather than the market price.

 

The Company assessed the materiality of these misstatements on prior periods’ financial statements in accordance with SEC Staff Accounting Bulletin (“SAB”) No. 99, Materiality, codified in ASC 250 (“ASC 250”), Presentation of Financial Statements, and concluded that these misstatements were not material to any prior annual or interim periods. Accordingly, in accordance with ASC 250 (SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements).

 

A reconciliation from the amounts previously reported for the Affected Periods to the restated amounts in the Restated Financial Statements is provided for the impacted financial statement line items below for the balance sheets as of June 30, 2023 and September 30, 2023. The amounts labeled “Restatement Adjustments” represent the effects of the Restatement Adjustments.

 

The Restatement Adjustments for the periods ending June 30, 2023, September 30, 2023 can be found in the Company’s amended Form 10-Q for the nine months ending September 30, 2023, filed on December 13, 2024.

 

   As Reported   Adjustment   As Restated 
Balance Sheet
(Unaudited)
  As of June 30, 2023 
   As Reported   Adjustment   As Restated 
             
Additional paid in capital  $26,137,940   $(576,160)  $25,561,780 
Accumulated deficit  $(31,798,754)  $576,160   $(31,222,594)

 

9

 

 

   As Reported   Adjustment   As Restated 
     
Balance Sheet
(Unaudited)
  As of September 30,
2023
 
   As Reported   Adjustment   As Restated 
                
Additional paid in capital  $32,469,830   $(576,160)  $31,893,670 
Accumulated deficit  $(32,856,462)  $576,160   $(32,280,302)

 

   As Reported   Adjustment   As Restated 
Statement of Operations
(Unaudited)
  For the six months ended June 30,
2023
 
   As Reported   Adjustment   As Restated 
             
General and administrative  $3,516,306   $(576,160)  $2,940,146 
Total operating expenses   4,064,511    (576,160)   3,488,351 
Loss from operations   (4,016,549)   576,160    (3,440,389)
Net loss   (4,037,021)   576,160    (3,460,861)
Loss per share - basic and diluted  $(0.15)  $0.02   $(0.13)

 

   As Reported   Adjustment   As Restated 
Statement of Operations
(Unaudited)
  For the nine months ended September 30,
2023
 
   As Reported   Adjustment   As Restated 
             
General and administrative  $4,031,452   $(576,160)  $3,455,292 
Total operating expenses   5,120,391    (576,160)   4,544,231 
Loss from operations   (5,063,267)   576,160    (4,487,107)
Net loss   (5,094,729)   576,160    (4,518,569)
Loss per share - basic and diluted   (0.18)   0.02    (0.16)

 

   As Reported   Adjustment   As Restated 
Statement of Cash Flows
(Unaudited)
  For the six months ended June 30,
2023
 
   As Reported   Adjustment   As Restated 
             
Cash Flows from Operating Activities:               
Net loss  $(4,037,021)  $576,160   $(3,460,861)
Additional shares issued for prior year software acquisition   2,794,882    (576,160)   2,218,722 
Net cash used in operating activities  $(960,625)  $   $(960,625)

 

   As Reported   Adjustment   As Restated 
Statement of Cash Flows
(Unaudited)
  For the nine months ended September 30,
2023
 
   As Reported   Adjustment   As Restated 
             
Cash Flows from Operating Activities:               
Net loss  $(5,094,729)  $576,160   $(4,518,569)
Additional shares issued for prior year software acquisition   2,794,882    (576,160)   2,218,722 
Net cash used in operating activities  $(1,545,458)  $   $(1,545,458)

 

Note 4. Going Concern

 

These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of September 30, 2024, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has no formal plan in place to address this concern but considers that the Company will be able to obtain additional funds by equity financing and/or related party advances, however, there is no assurance of additional funding being available.

 

Note 5. Related Party Transactions

 

Advances, related party

 

During the nine months ended September 30, 2024, Mr. Day advanced the Company $72,000 and was repaid $72,000. The advances are unsecured, non-interest bearing and are payable on demand. As of September 30, 2024, the advances, related party balance owed to Mr. Day were $0.

 

10

 

 

Expense paid on the Company’s behalf

 

During the nine months ended September 30, 2024 and 2023, Mr. Day paid $249,113 and $352,952 of expenses on the Company’s behalf and was repaid $213,042 and $262,850, respectively. As of September 30, 2024 and December 31, 2023, the balance owed to Mr. Day was $40,408 and $4,337, respectively.

 

During the nine months ended September 30, 2024, Mr. Leal paid $8,862 of expenses on the Company’s behalf. As of September 30, 2024, the balance owed to Mr. Leal was $8,862.

 

Founder note

 

Rowland Day, the Company’s prior CEO agreed to provide the necessary working capital for the Company’s business. At the end of each calendar quarter the convertible promissory note is adjusted based upon the funds provided. The convertible promissory note bears interest at 5% and was originally convertible into Series B-1 preferred stock at the rate of $0.10 per share. On October 1, 2023, with no consideration given, Mr. Day agreed to waive the convertible feature on the note payable, related party. During the nine months ended September 30, 2024 and 2023, this Company recorded imputed interest expense of $4,995.

 

As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $221,990, with accrued interest of $41,623 and $33,299, respectively.

 

Senior secured notes payable

 

On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

11

 

 

On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024. The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

12

 

 

On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

As of September 30, 2024 and December 31, 2023, the note payable, related party principal balance was $549,000 and $0, with accrued interest of $37,904 and $0, respectively.

 

Accrued salary and interest

 

On October 1, 2023, the Company and Mr. Day entered into a settlement and general release agreement. Per the agreement, Mr. Day agreed to settle all accrued salary and interest for service provided prior to September 1, 2022. As a result, the Company recorded a settlement of $351,459 as a contribution to capital during the year ended December 31, 2023. During the nine months ended September 30, 2024, the Company recorded an additional $4,448 as a contribution to capital related to the settlement.

 

Note 6. Equity

 

The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

 

On May 1, 2023, the Articles of Incorporation of the Company were amended to increase the authorized B-1 preferred shares to 8,619,420 shares.

 

Common Stock

 

On February 6, 2024, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000.

 

During the quarter ended June 30, 2024, the Company issued 582,000 shares of common stock at $0.80 per share and collected $465,600.

 

13

 

 

During the quarter ended September 30, 2024, the Company issued 300,000 shares of common stock at $0.75 per share and collected $225,000.

 

Preferred Stock

 

Series A Convertible Preferred Stock

 

In April 2008, our board of directors designated 5,000,000 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended to decrease the authorized Series A shares to 2,068 shares of Series A. Series A has liquidation and dividend preferences. Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. Each share of Series A is convertible on a 1 to 1.25 common share basis. As of each of September 30, 2024 and December 31, 2023, there were 2,068 shares of Series A issued and outstanding.

 

Series B-1 Convertible Preferred Stock

 

In October 2015, our board of directors designated 3,107,438 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with the redemption value of $0.70798 per share. Series B-1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible. Each share of Series B-1 is convertible on a 1 to 11 common share basis. The Company’s Articles of Incorporation require 51% of the outstanding votes of the Series B-1 to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. Series B-1 was included in mezzanine equity on the balance sheet, because it was convertible at the redemption value into a variable number of shares. On May 2, 2023, the Board approved an addendum to the Share Exchange Agreement previously entered into on August 1, 2022, between the Company, Metalanguage, and Saul Leal. The Addendum provided for the additional issuance of 2,946,074 shares of Series B-1 Convertible preferred stock to the sole shareholder of Metalanguage who is also the CEO of the Company, Saul Leal. The Board approved the transaction to better align incentives in connection with our Acquisition of MetaLanguage given Mr. Leal’s importance to the Company in continuing to lead and expand the business acquired from him. On September 30, 2023, the Articles of Incorporation of the Company were amended to remove the redemption right of the Series B-1, which was subsequently reclassified from mezzanine equity to permanent equity on the balance sheet. As of September 30, 2024 and December 31, 2023, there are 8,619,420 shares of Series B-1 issued and outstanding.

 

Series B-2 Convertible Preferred Stock

 

In October 2015, our board of directors designated 3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended such that no Series B-2 shares are authorized. Series B-2 have no liquidation or dividend preferences. Each share of Series B-2 has voting rights equal to the amount of shares of common stock the Series A is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of September 30, 2024 and December 31, 2023, there are no shares of Series B-2 issued and outstanding.

 

Stock Warrants

 

The following table summarizes the stock warrant activity for the nine months ended September 30, 2024:

 

   Warrants  

Weighted-Average

Exercise

Price Per Share

 
Outstanding, December 31, 2023   350,000   $1.29 
Granted        
Exercised        
Forfeited        
Expired        
Outstanding, September 30, 2024   350,000   $1.29 

 

14

 

 

As of September 30, 2024 the outstanding and exercisable warrants have a weighted average remaining term of 3.56 with no intrinsic value, respectively.

 

Stock Options

 

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual installments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

 

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i )50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $39,546.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 years, Volatility 120.76% and Discount rate 3.62%.

 

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested. The total fair value of these option grants at issuance was $52,021.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

 

During the nine months ended September 30, 2024, the Company recognized $271,924 of expense related to outstanding stock options.

 

The following table summarizes the stock option activity for the nine months ended September 30, 2024:

 

   Options  

Weighted-Average

Exercise

Price Per Share

 
Outstanding, December 31, 2023   3,645,000   $0.43 
Granted   970,000    0.52 
Exercised        
Forfeited        
Expired        
Outstanding, September 30, 2024   4,615,000   $0.43 
Exercisable, September 30, 2024   580,000   $0.46 

 

As of September 30, 2024, the outstanding and exercisable options have a weighted average remaining term of 4.96 with an intrinsic value of $47,450.

 

15

 

 

Note 7: Commitments

 

On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers.

 

One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

 

Note 8: Subsequent Events

 

On October 8, 2024, the Company entered into an OEM Agreement (the “Agreement”) with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel, whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. NICE is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language translation solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. The Agreement has an exclusivity period of eighteen months and an initial term of three years. Subsequent to September 30, 2024, the Company received $700,000 related to this agreement.

 

On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . The Company will not hereafter create, incur, assume, or suffer to exist any mortgage, pledge, hypothecation, assignment, security interest, encumbrance, lien (statutory or other), preference, priority, of other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any financing lease) (each a “Lien”) upon any of its property, revenue, or assets, whether now owned or hereafter acquired without the written consent of Holder. The Company shall cross-default in the payment when due, or otherwise default in performance, after the expiration of any applicable grace period, of any amount payable under existing corporate obligations, or any other obligations of the Company for money borrowed (including capital leases and purchase money financing) in excess of $10,000, or there occurs any event of default or similar circumstance or event entitling the holder thereof to accelerate the obligations thereunder or to exercise rights and remedies, prior to the payment in full of the obligations. If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. To secure the prompt and complete payment of all Secured Obligations, for value received and pursuant to the Note, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

 

On October 29, 2024, the Company agreed to issue 1,200,000 options to an employee. The options have a five-year term at an exercise price of $0.75 and vest in 4 equal annual installments beginning one year from the issuance date. The options vest as follows: (i) 600,000 options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning June 30, 2024, and ending on March 31, 2028, until the 600,000 Options are 100% vested. In full satisfaction of the relevant obligation of the Company under the Participant’s employment agreement with the Company, the remaining 600,000 Options will become vested and exercisable as follows until the Option is 100% vested (ii) for a period of four years beginning April 1, 2024, ending March 31 of 2025; April 1, 2025, ending March 31, 2026; April 1, 2026 ending March 31, 2027; and April 1, 2027 ending March 31, 2028, 150,000 Options will vest (subject to meeting certain total new bookings) on March 31 of each year, beginning March 31, 2025. Vesting for each 12-month term is contingent upon Participant exceeding a minimum amount of total new bookings as determined by the Company’s board of directors or their designee. For the 2 first term ending on March 31, 2025. Participant must exceed $5 million of total new bookings for the first vesting of 150,000 options.

 

16

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion of our financial condition and results of operations in conjunction with the condensed financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and with our audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”). In addition to historical condensed financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

 

Overview

 

The Company operates to develop artificial intelligence products that enable companies and individuals to reach their highest potential by eliminating language barriers in daily communications by providing high-quality, accurate, and efficient interpretation and translation services using natural language processing (NLP) technology. The Company’s focus is on developing a proprietary architecture that is faster and more accurate than any other company, with a commitment to providing superior quality services to its customers. The Company intends to serve a wide variety of markets and customers and will be focused on becoming a leader in the creation of pragmatic products for the interpretation and translation industry.

 

Business Summary

 

At the time of its initial formation in 2006, the Company was a development stage company that offered live promotions and marketing events using custom-built mobile displays.

 

Today, the Company is developing a stack of cutting-edge artificial intelligence technologies that solve everyday problems with an innovative and pragmatic approach. Using natural language processing sentiment analytics and behavioral prediction to metaverse enhancement, the Company is attempting to solve problems that will elevate our human condition.

 

The Company has recently launched two products: Verbum, which is a platform that enables fluent and effective communication among individuals that do not speak the same language; and Verbum SDK. Verbum SDK is a software development kit that allows developers to create multi-language translation tools for their own use.

 

Our Products

 

The Company’s current products described in detail below have proprietary technology and associated patents. The Company is currently working on patents for future product offerings.

 

  Verbum. Verbum supports real time web-based conversations, discussions, meetings, and online chats in 150 languages, enabling fluent and effective communication among individuals that do not speak the same language. This product is distributed through our online platform, direct sales to businesses and organizations, and we are attempting to develop partnerships with existing video conferencing providers. The competitive position is against other video conferencing providers that also offer live interpretation services, such as Microsoft Teams, Zoom and Google Meet. We believe our main competitors are organizations that supply human interpreters which can be ten times more expensive than our Verbum product. The primary market for our Verbum product is for organizations or individuals that require real-time interpretation services.
     
  Verbum SDK. Verbum Software Developer Kit allows software programmers, potential channel partners, and corporate development teams to integrate our powerful multilingual communications platform Verbum™ — into new or existing Software-as-a-Service applications and/or client/server programs, helping them remove communications barriers for multinational organizations and/or those serving customers who speak/read different languages. This product may be distributed through partnerships with software developers or through direct sales to businesses and organizations that require interpretation services for their software. The competitive position would be against other software development kit providers that also offer interpretation services, such as Microsoft Azure or Amazon Translate. The expected market for this product is software developers and businesses that require interpretation services for their software applications.

 

17

 

 

 

Components of Our Results of Operations

 

Net Revenue

 

We currently derive our revenue primarily from the sale of our products. We expect our net revenue to increase in the foreseeable future as we add new customers and offer additional products, though net revenue may fluctuate from quarter to quarter due to a variety of factors, including the pace of research and development and completion of additional products.

 

Operating Expenses

 

Operating expenses consist primarily of research and development, salaries and benefits, infrastructure and equipment, professional services and distribution and delivery.

 

Research and Development: Developing and maintaining the proprietary NLP technology and architecture will be a significant future expense for the Company. This will include expenses related to hiring and retaining top talent, conducting research and development, and investing in technology infrastructure and equipment.

 

Salaries and Benefits: The Company plans to invest in hiring and retaining additional employees to perform various functions, such as software development, customer support, sales, and administration. This will include salaries, benefits, and other employee-related expenses.

 

Infrastructure and Equipment: The Company will invest in technology infrastructure and equipment to support its software development and distribution operations. This will include expenses related to servers, software licenses, hardware, and office equipment.

 

Professional Services: Depending on the Company’s needs, it may need to engage professional services such as legal, accounting, or consulting services, which would be an expense for the Company.

 

Distribution and Delivery: The Company will need to invest in distribution and delivery methods for its products, such as software updates, shipping, or online delivery. This will include expenses related to logistics, software licensing, or server maintenance.

 

Total Other Expense

 

Other expenses consist primarily of interest expense. It also includes any gains and loss attributable to the changes in fair market value from the derivative liabilities associated with the issuance of convertible notes.

 

18

 

 

Results of Operations for the Three Months Ended September 30, 2024 and 2023

 

The following table summarizes selected items from the statement of operations for the three months ended September 30, 2024 and 2023, respectively.

 

   Three months
ended
   Three months
ended
  


 
  

September 30,

2024

  

September 30,

2023

  

Increase/

(Decrease)

 
             
Revenue  $3,478   $9,162   $(5,684)
Total revenue   3,478    9,162    (5,684)
                
Operating expenses:               
Research and development   202,168    203,588    (1,420)
General and administrative   537,164    515,146    22,018 
Advertising and marketing   25,336    71,253    (45,917)
Legal and professional   139,600    265,893    (126,293)
                
Total operating expenses   904,268    1,055,880    (151,612)
                
Loss from operations   (900,790)   (1,046,718)   (145,928)
                
Other expense:               
                
Interest expense   (34,563)   (10,990)   23,573 
                
Total other expense   (34,563)   (10,990)   23,573 
                
Net loss  $(935,353)  $(1,057,708)  $(122,355)

 

Net Revenue

 

Our net revenue for the three months ended September 30, 2024 was $3,478, compared to $9,162 for the three months ended September 30, 2023, a decrease of $5,684. We had little revenue for both periods as our products have been in the development stage and we have not secured any large-scale customer contracts.

 

Operating Expenses

 

Our total operating expenses for the three months ended September 30, 2024, were $904,268, compared to $1,055,880 for the three months ended September 30, 2023, a decrease of $151,612. The decrease in our operating expenses was primarily a result of: (i) a decrease in advertising and marketing expenses, from $71,253 for the three months ended September 30, 2023 to $25,336 for the three months ended September 30, 2024; and (ii) a decrease in legal and professional expenses, from $265,893 for the three months ended September 30, 2023 to $139,600 for the three months ended September 30, 2024.

 

Other Expense

 

For the three months ended September 30, 2024, other expense was $34,563. For the three months ended September 30, 2023, other expense was $10,990. Other expense increased by $23,573 primarily due to an increase in interest expense for senior secured notes in 2024.

 

19

 

 

Net Loss

 

Net loss for the three months ended September 30, 2024, was $935,353, compared to $1,057,708 for the three months ended September 30, 2023, a decreased net loss of $122,355. The decreased net loss was primarily due to a $145,928 decrease in operating expenses.

 

Results of Operations for the Nine Months Ended September 30, 2024 and 2023

 

The following table summarizes selected items from the statement of operations for the nine months ended September 30, 2024 and September 30, 2023, respectively.

 

   Nine months
 ended
   Nine months
 ended
     
  

September 30,

2024

  

September 30,

2023

   Increase/
(Decrease)
 
             
Revenue  $14,354   $57,124   $(42,770)
Total revenue   14,354    57,124    (42,770)
                
Operating expenses:               
Research and development   653,732    540,092    113,640 
General and administrative   1,672,388    3,455,292    (1,782,904)
Advertising and marketing   78,809    161,038    (82,229)
Legal and professional   491,733    387,809    103,924 
                
Total operating expenses   2,896,662    4,544,231    (1,647,569)
                
Loss from operations   (2,882,308)   (4,487,107)   1,604,799
                
Other expense:               
                
Interest expense   (60,655)   (31,462)   29,193 
                
Total other expense   (60,655)   (31,462)   29,193 
                
Net loss  $(2,942,963)  $(4,518,569)  $1,575,606

 

Net Revenue

 

Our net revenue for the nine months ended September 30, 2024 was $14,354, compared to $57,124 for the nine months ended September 30, 2023, a decrease of $42,770. We had little revenue for both periods as our products have been in the development stage and we have not secured any large-scale customer contracts.

 

20

 

 

Operating Expenses

 

Our total operating expenses for the nine months ended September 30, 2024, was $2,896,662, compared to $4,544,231 for nine months ended September 30, 2023, a decrease of $1,647,569. The decrease in our operating expenses was primarily a result of a decrease in (i) general and administrative expenses, from $3,455,292 for nine months ended September 30, 2023 to $1,672,388 for nine months ended September 30, 2024, and (ii) advertising and marketing expenses, from $161,038 for nine months ended September 30, 2023 to $78,809 for nine months ended September 30, 2024.

 

Other Expense

 

In the nine months ended September 30, 2024, other expense was $60,655. For the nine months ended September 30, 2023, other expense was $31,462. Other expense increased by $29,193 primarily due to an increase in interest expense for senior secured notes in 2024.

 

Net loss

 

Net loss for the nine months ended September 30, 2024 was $2,942,963, compared to $4,518,569 for the nine months ended September 30, 2023, a decrease of $1,575,606. The decrease in net loss was primarily due to a $1,647,569 decrease in operating expenses.

 

Liquidity and Capital Resources

 

The following table summarizes our total current assets, liabilities and working capital as of September 30, 2024 and December 31, 2023.

 

   September 30,   December 31, 
   2024   2023 
Current Assets  $46,606   $1,143,690 
           
Current Liabilities  $1,864,831   $1,025,919 
           
Working Capital (Deficit)  $(1,818,225)  $117,771 

 

As of September 30, 2024, we had a working capital deficit of $1,818,225. We have incurred net losses since our inception and we anticipate net losses and negative operating cash flows for the near future and we may not be profitable or realize growth in the value of our assets. To date, our primary sources of capital have been cash generated from common stock sales and debt financing. As of September 30, 2024, we had cash of $24,254, total liabilities of $1,864,831, and an accumulated deficit of $36,851,759. As of December 31, 2023, we had cash of $1,129,935, total liabilities of $1,025,919, and an accumulated deficit of $33,908,796.

 

Cash Flow

 

Comparison of the Nine Months Ended September 30, 2024 and the Nine Months Ended September 30, 2023

 

The following table sets forth the primary sources and uses of cash for the periods presented below:

 

   Nine Months Ended 
   September 30, 
   2024   2023 
Net cash used in operating activities  $(2,380,281)  $(1,545,458)
Net cash provided by financing activities   1,274,660    1,358,000 
           
Net change in cash  $(1,105,681)  $(187,458)

 

21

 

 

Net Cash Used in Operating Activities

 

Net cash used in operating activities was $2,380,281 for the nine months ended September 30, 2024, compared to $1,545,458 for the nine months ended September 30, 2023, an increase of $834,823. The change was primarily attributable to increases in non-cash expenses related to stock-based compensation , accrued expenses and deferred revenue.

 

Net Cash Provided by Financing Activities

 

Net cash provided by financing activities was $1,274,660 for the nine months ended September 30, 2024, compared to $1,358,000 for the nine months ended September 30, 2023, a decrease of $83,340. The decrease in cash provided by financing activities was primarily attributable to our decrease in sales of our common stock which were offset by increases in proceeds from senior secured notes payable, related party.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our financial results are affected by the selection and application of accounting policies and methods. In the nine-month period ended September 30, 2024, there were no changes to the application of critical accounting policies previously disclosed in the 2023 Form 10-K.

 

CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS

 

This report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are “forward-looking statements” for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of our management for future operations, any statements concerning proposed new products or services, any statements regarding the integration, development or commercialization of the business or any assets acquired from other parties, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “potential,” “forecasts,” “continue,” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results will likely differ, and could differ materially, from those projected or assumed in the forward-looking statements. Investors are cautioned not to unduly rely on any such forward-looking statements.

 

All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Our actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. If we do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections.

 

NOTICE REGARDING TRADEMARKS

 

This report includes trademarks, tradenames and service marks that are our property or the property of others. Solely for convenience, such trademarks and tradenames sometimes appear without any “™” or “®” symbol. However, failure to include such symbols is not intended to suggest, in any way, that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.

 

22

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management is responsible for establishing and maintaining adequate disclosure controls and procedures for our company. Consequently, our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act as of September 30, 2024. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

During the nine-month period ended September 30, 2024, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934).

 

23

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not currently party to any pending legal proceedings that we believe would, individually or in the aggregate, have a material adverse effect on our financial condition, cash flows or results of operations.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide information typically disclosed under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Common Stock

 

On February 6, 2024, the Company issued 87,500 shares of common stock at $0.40 per share and collected $35,000.

 

During the three months ended June 30, 2024, the Company issued 582,000 shares of common stock at $0.80 per share and collected $465,600.

 

During the three months ended September 30, 2024, the Company issued 300,000 shares of common stock at $0.75 per share and collected $225,000.

 

Stock Warrants

 

As of September 30, 2024 the outstanding and exercisable warrants have a weighted average remaining term of 3.56 with no intrinsic value, respectively.

 

Stock Options

 

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual installments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

 

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i )50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $39,546.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 years, Volatility 120.76% and Discount rate 3.62%.

 

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028 until the Option is 100% vested. The total fair value of these option grants at issuance was $52,021.The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

 

During the nine months ended September 30, 2024, the Company recognized $271,924 of expense related to outstanding stock options.

 

As of September 30, 2024, the outstanding and exercisable options have a weighted average remaining term of 4.96 with an intrinsic value of $47,450.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

The disclosure required by this item is not applicable.

 

ITEM 5. OTHER INFORMATION

 

During the nine months ended September 30, 2024, no director or officer adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.

 

24

 

 

ITEM 6. EXHIBITS.

 

Exhibit   Description
3.1**   Amended and Restated Articles of Incorporation.
3.2**   Amended and Restated Bylaws.
3.4**   ONEMETA AI – NV – Secretary of State – Amendment Filing
3.5**   Amendment to Certificate of Designation Series B
3.6**   Certificate of Designation Final – Series A-1
3.7**   Certificate of Designation Series B-1 and Related Certificates of Change
21.1**   Subsidiaries of OneMeta Inc.
31.1*   Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
31.2*   Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a)
32.1*   Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

* Filed herewith
** Previously filed
Indicates management contract or compensatory plan or arrangement

 

25

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registration has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Signature   Title   Date
         
/s/ Saul Leal   Chief Executive Officer   December 13, 2024
Saul Leal   (Principal Executive Officer)    
         
/s/ Rowland Day   President, Chief Financial Officer   December 13, 2024
Rowland Day   (Principal Accounting and Financial Officer)    

 

26